Moderna (MRNA) ebitda was -$2.4B in FY2025 (+29% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
-$2.4B
+29%
2024
-$3.3B
-0%
2023
-$3.3B
-133%
2022
$10.0B
-27%
2021
$13.7B
+2239%
2020
-$639M
-47%
2019
-$434M
-37%
2018
-$316M
-51%
2017
-$209M
-23%
2016
-$169M
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
-$639M
Q1 2026
-$1.2B
Q4 2025
-$678M
Q3 2025
-$84M
Q2 2025
-$721M
Q1 2025
-$897M
Q4 2024
-$1.1B
Q3 2024
$93M
Q2 2024
-$1.2B
Q1 2024
-$1.1B
Q4 2023
$288M
Q3 2023
-$1.7B
Source: MRNA on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.